share_log

Goldman Sachs Adjusts Bioventus' Price Target to $13 From $15, Maintains Neutral Rating

Goldman Sachs Adjusts Bioventus' Price Target to $13 From $15, Maintains Neutral Rating

高盛將Bioventus的目標股價從15美元調整至13美元,維持中性評級
MT Newswires ·  2022/09/07 10:41

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論